2015, Cancer and Medicaid - Cardiovascular Update

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2015

Cancer

Medicaid

Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation

Circulation: Cardiovascular Quality & Outcomes

MARCH 5, 2024

In 2020, patients had higher odds of initiating LAAO use than in 2015 (0.52 0.68]) versus White race, and Medicaid eligibility (aOR, 0.61 [95% CI, 0.58–0.64]) 0.68]) versus White race, and Medicaid eligibility (aOR, 0.61 [95% CI, 0.58–0.64]) versus 9.32%; adjusted odds ratio [aOR], 13.64 [95% CI, 12.56–14.81]).

Atrial Fibrillation

Atrial Fibrillation Medicaid Cancer Medicare

Abstract 129: Endovascular Therapy in Cerebral Venous Thrombosis: Nationwide Insights and Implications for Mortality

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

We examined the demographic and clinical correlates of EVT use in CVT and assessed its impact on patient outcomes utilizing a national database.MethodsWe identified CVT cases from 2015 to 2020 in the National Inpatient Sample, with EVT as the primary exposure. 0.48, p=0.001), CNS cancer (OR: 0.24, 95% CI: 0.06‐0.93,

Thrombosis

Thrombosis Cancer Inpatient Hospital

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Patient Characteristics Associated With Using Transcatheter Left Atrial Appendage Occlusion Versus Oral Anticoagulants for Atrial Fibrillation

Abstract 129: Endovascular Therapy in Cerebral Venous Thrombosis: Nationwide Insights and Implications for Mortality

Webinars

Stay Connected